Top.Mail.Ru

Ночная изжога – выход есть

Раздел только для специалистов в сфере медицины, фармации и здравоохранения!

 4005

Ночная изжога – выход есть

Журнал "Медицинский совет. Гастроэнтерология" №14, 2018



В.И. Симаненков, С.В. Тихонов, Н.Б. Лищук, ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова», Минздрава России, Санкт-Петербург

Статья посвящена проблеме ночной изжоги, особенностям этиопатогенеза ночных гастроэзофагеальных рефлюксов, диагностике и рациональной терапии ночных проявлений ГЭРБ.

V.I. Simanenkov, S.V. Tikhonov, N.B. Lishchuk, Mechnikov North-Western State Medical University of the Ministry of Health of Russia, St.Petersburg 

Nocturnal heartburn: there is a solution 

This article describes a problem of sleep disorders, nighttime heartburn, the peculiarities of etiopathogenesis of night gastroesophageal reflux, the possibility of diagnosis and rational therapy of nighttime heartburn.

Ночная изжога – выход есть

Загрузить файл


Список литературы

1. Ковальзон В.М. Основы сомнологии. Физиология и нейрохимия цикла бодрствование - сон. М.: Бином. Лаборатория знаний, 2012. 240 с.

2. Ковальзон В.М. Нейрофизиология и нейрохимия сна. Сомнология и медицина сна. Избранные лекции. Под ред. Я.И. Левина, М.Г. Полуэктова. М., 2013: 67-91.

3. International classification of sleep disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, Illinois: American Academy of Sleep Medicine, 2005. 298 p.

4. Левин Я.И., Ковров Г.В., Полуэктов М.Г. и др. Инсомния, современные диагностические и лечебные подходы. М.: Медпрактика-М, 2005. 115 с.

5. Полуэктов М.Г., Левин Я.И. Инсомния. Сомнология и медицина сна. Избранные лекции. Под ред. Я.И. Левина и М.Г. Полуэктова. М.: Медфорум-альфа, 2013:192-220.

6. Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med, 2007, 3(5): 7-10.

7. Ляшенко Е.А., Левин О.С. Расстройства сна в клинической практике. Современная терапия в психиатрии и неврологии, 2017, 1: 22-28.

8. Полуэктов М.Г. Клинический алгоритм диагностического и лечебного выбора при инсомнии. Эффективная фармакотерапия, 2013, 12: 22-28.

9. Vakil N, van Zanden SV, Kahrilas P et al. The Monreal definition and classification of gas troesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol, 2006, 101: 1900-1920.

10. Лазебник Л.Б., Машарова А.А., Бордин Д.С. и др. Результаты многоцентрового исследования «Эпидемиология гастроэзофагеальной рефлюксной болезни в России» («МЭГРЭ»). Тер. арх., 2011, 1: 5-50.

11. Ивашкин В.Т., Маев И.В., Трухманов А.С. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Рос. журн. гастроэнтерол. гепатол. колопроктол., 2017, 27(4): 75-95.

12. Farup C, Kleinman L, Sloan S et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med, 2001, 161: 45-52.

13. Janson C, Gislason T, De Backer W et al. Daytime sleepiness, snoring and gastrooesophageal reflux amongst young adults in three European countries. J Intern Med, 1995, 237: 277-285.

14. Janson C, De Backer W, Gislason T et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: A population study of young adults in three European countries. Eur Respir J, 1996, 9: 2132-2138.

15. Janson C, Gislason T, De Backer W et al. Insomnia and sleep. Prevalence of sleep disturbances among young adults in three European countries. Sleep, 1995, 18: 589-597.

16. Kruse-Anderson S, Wallin L, Madsen T. Acid gastroesophageal reflux and oesophageal pressure activity during postprandial and nocturnal periods: a study in subjects with and without pathologic acid gastro-oesophageal reflux. Scand J Gastroenterol, 1987, 22: 926-930.

17. Farup C, Kleinman L, Sloan S et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med, 2001, 161: 45-52.

18. Dean BB, Aguilar D, Johnson LF et al. The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity. Dig Dis Sci, 2009, 55: 952-959.

19. Mody R, Bolge SC, Kannan H et al. Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol, 2009, 7: 953-959.

20. Shaker R, Castell DO, Schoenfeld PS et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol, 2003, 98: 1487-1493.

21. Dent J, Armstrong D, Delaney B et al. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion output. Gut, 2004, 53(4): 1-24.

22. Harding SM. Gastroesophageal reflux during sleep. Sleep Med Clin, 2007, 2: 41-50.

23. Sozzi M, Valentini M, Polefti M. Nocturnal gastric acidity pattern in gastro-oesophageal reflux disease with or without oesophagitis. Ital J Gastroenterol, 1995, 27: 413-418.

24. Mainie I et al. Acid and non-acid reflux in patient with persistent symptoms despite acidsupperesive therapy: a multicenter study using combined ambulatory impedance-pHmonitoring. Gut, 2006, 55: 1398.

25. Sharma N et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pHmonitoring. Clin Gastroenterol Hepatol, 2008, 6: 521.

26. Karamanolis G et al. Esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Scl, 2008, 53: 2387.

27. Clinard V et al. GERD-related sleep disturbances. US Pharm, 2012, 37(1): 36-39.

28. Hershcovici T, Fass R. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol, 2010, 26(4): 367-78.

29. Лобанова Е. Ночной кислотный прорыв: тема для диалога. МедФарм Вестник Поволжья, 2011, 43.

30. Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology, 1998, 115: 1335-1339.

31. Васильев Ю.В. Ингибиторы протонного насоса. Лечащий врач, 2007, 1: 3-7.

32. Krznaric Z, Ljubas KD Rustemovic N, Vranesic BD, Ostojic R, Markos P, Scarpignato C. Pharmaceutical principles of acid inhibitors: unmet needs. Dig Dis, 2011, 29(5): 469-475.

33. Hatlebackk JG, Katz PO, Kuo B, Castell DO. Nocturnal gastric acidity and breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther, 1998, 12: 1235-1240.

34. Fock KM, Ang TL, Bee LC, Lee EJ. Proton pump inhibitors: do differences in pharmacokinetics translate into differences in clinical outcomes? Clin Pharmacokinet, 2008, 47(1): 1-6.

35. Bredenoord AJ, Smout AJ. Refractory gastrooesophageal reflux disease. Aliment Pharmacol Ther, 2007, 26(9): 1259-1265.

36. Пасечников В.Д., Пасечников Д.В. Клиническое значение феномена ночного кислотного прорыва при применении ингибиторов протонной помпы. Фарматека, 2004, 13(90): 28-32.

37. Calleja JL, Bixquert M, Maldonado J. Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study. Dig Dis Sci, 2007, 52: 2858-2865.

38. Dubois RW, Aguilar D, Fass R et al. Consequences of frequent nocturnal gastrooesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther, 2007, 25: 487-500.

39. Dean BB, Crawley JA, Schmitt CM et al. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther, 2003, 17: 1309-1317.

40. Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res, 2001, 10: 331-345.

41. Schey R et al. Sleep deprivationis hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology, 2007, 133: 1787-1795.

42. Hakki Onen S et al. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res, 2001, 10: 35-42.

43. Tack J. Pathophysiology of Gastroesopageal Reflux Disease. Gastroenterology, 2018, 154: 277-288.

44. Gaddam S, Maddur H et al. Risk Factors for nocturnal reflux reflux in a large GERD cohort. J Clin Gastroenterology, 2011, 45(9): 764-768.

45. Leggett CL et al. Obstructive sleep apnea is a risk factor for Barrett’s esophagus. Clin Gastroenterol Hepatol, 2013, 11: 1542-3565.

46. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med, 1999, 340: 825-831.

47. DeMeester TR, Johnson LF, Guy JJ et al. Patterns of Gastroesophageal reflux in health and disease. Ann Surg, 1996, 184: 459-470.

48. Peura D. The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole. Aliment Pharmacol Ther, 2013, 37: 810-818.

49. Zhang W. Pharmacokinetics and safety of dexlansoprazole mr in adolescents with symptomatic GERD. Gastroenterology, 2007, 132: 285-293.

50. Fass R, Chey WD, Zakko SF. Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease. Aliment Pharmacol Ther, 29: 1261-1272.

51. Fass R, Johnson DA. The effect of dexlansoprazole MR on nocturnal heartburn and GERDrelated sleep disturbances in patients with symptomatic GERD. Am J Gastroenterol, 2011, 106: 421-431.

52. Metz DC, Howden CW, Perez MC, Larsen L, O’Neil J, Atkinson SN. Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed-release technology, effectively controls symptoms and prevents relapse in patients with healed erosive. Aliment Pharmacol Ther, 2009, 29: 742-754.

53. Fass R et al. Management of heartburn notresponding to proton pump inhibitors. Gut, 2009, 58(2): 295-309.

54. Kukulka M, Eisenberg C, Nudurupati S. Comparator pH study to evaluate the singledose pharmacodynamics of dual delayedrelease dexlansoprazole 60 mg and delayedrelease esomeprazole 40 mg. Clin and Experimental Gastroenterology, 2011, 4: 213-220.





Последние статьи